Literature DB >> 12867644

Positive and negative effects of adeno-associated virus Rep on AAVS1-targeted integration.

Masashi Urabe1,2,3, Katsuhiro Kogure2,3, Akihiro Kume2,3, Yuko Sato4, Kiyotake Tobita1, Keiya Ozawa2,3.   

Abstract

Adeno-associated virus type 2 integrates preferentially into the AAVS1 locus on chromosome 19 of the human genome. It was reported previously that transfection with two plasmids, one for Rep and the other carrying a transgene flanked by inverted terminal repeats (ITRs), enables preferential integration of the latter into AAVS1. Aiming at increasing the frequency of AAVS1-specific integration, the Rep- to transgene-plasmid ratio necessary to achieve a higher frequency of site-specific integration was examined. 293 cells were co-transfected with the Rep78 plasmid and an ITR-flanked Neo gene at different ratios. G418-resistant clones were selected randomly. Extensive Southern blot analysis showed an optimum range of Rep78 expression. In that range, approximately 20 % of clones harboured the Neo gene at AAVS1. Excess Rep expression, however, resulted in 'abortive' integration of the Neo gene, a rearrangement of AAVS1 without transgene integration. Rep78 appeared to cause abortive integration more extensively than Rep68. Deleterious effects of the Rep protein on the AAVS1 locus should be considered to develop an improved AAVS1-targeted system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12867644     DOI: 10.1099/vir.0.19193-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  6 in total

1.  Highly divergent integration profile of adeno-associated virus serotype 5 revealed by high-throughput sequencing.

Authors:  Tyler Janovitz; Thiago Oliveira; Michel Sadelain; Erik Falck-Pedersen
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

2.  Non-viral adeno-associated virus-based platform for stable expression of antibody combination therapeutics.

Authors:  Gwendolyn M Wilmes; Kimberly L Carey; Stuart W Hicks; Hugh H Russell; Jesse A Stevenson; Paulina Kocjan; Stephen R Lutz; Rachel S Quesenberry; Sergey V Shulga-Morskoy; Megan E Lewis; Ethan Clark; Violetta Medik; Anthony B Cooper; Elizabeth E Reczek
Journal:  MAbs       Date:  2014-04-23       Impact factor: 5.857

3.  Efficient AAV1-AAV2 hybrid vector for gene therapy of hemophilia.

Authors:  Bernd Hauck; Ray Ruian Xu; Jing Xie; Wenman Wu; Qiulan Ding; Matthew Sipler; Hongli Wang; Ling Chen; J Fraser Wright; Weidong Xiao
Journal:  Hum Gene Ther       Date:  2006-01       Impact factor: 5.695

4.  Adeno-associated virus site-specific integration and AAVS1 disruption.

Authors:  Henry Hamilton; Janette Gomos; Kenneth I Berns; Erik Falck-Pedersen
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

5.  High-throughput sequencing reveals principles of adeno-associated virus serotype 2 integration.

Authors:  Tyler Janovitz; Isaac A Klein; Thiago Oliveira; Piali Mukherjee; Michel C Nussenzweig; Michel Sadelain; Erik Falck-Pedersen
Journal:  J Virol       Date:  2013-05-29       Impact factor: 5.103

6.  Adeno-associated virus type 2 preferentially integrates single genome copies with defined breakpoints.

Authors:  Tyler Janovitz; Michel Sadelain; Erik Falck-Pedersen
Journal:  Virol J       Date:  2014-01-27       Impact factor: 4.099

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.